Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset)1
-
Year
- Journal Title
- Arch Dermatol Res1
Search Results
Sort by
- Bookeditors Elizabeth Buys, MD, Kristina Tocce, MD, MPH, Michele A. Manting, MD, MEd.Contents:
Preventive care
Ethics
Genetics
Obstetrics
Obstetrics screening and surveillance
Obstetrics high risk
Obstetrics postpartum
Breast and lactation
Gynecology
Contraception
Family planning
Sexually transmitted infections
Neoplasia
Menopause
Sexuality
Reproductive issues.Digital Access LWW Health Library (PA Rotations) 2015 - ArticleTheodoridis A, Sivenas C, Vagena A, Capetanakis J.Arch Dermatol Res. 1978 Jul 28;262(2):173-6.In a double blind trial adenine arabinoside (Vidarabine) and Idoxuridine (IDU) were tested in herpes simplex and herpes zoster infections. Adenine arabinoside covered 19 patients with HSV and 6 with HZ while IDU 19 with HSV and 6 with HZ. From the statistical analysis it was found that Vidarabine acts shorter than IDU in HSV P less than 0.01, while in HZ no significant difference P less than 0.5 was found, possibly due to the small number of patients tested.